BE848932A - Procede pour determiner in vitro dans le sang l'inhibiteur du facteur x active, - Google Patents

Procede pour determiner in vitro dans le sang l'inhibiteur du facteur x active,

Info

Publication number
BE848932A
BE848932A BE172864A BE172864A BE848932A BE 848932 A BE848932 A BE 848932A BE 172864 A BE172864 A BE 172864A BE 172864 A BE172864 A BE 172864A BE 848932 A BE848932 A BE 848932A
Authority
BE
Belgium
Prior art keywords
vitro
inhibitor
blood
factor
active
Prior art date
Application number
BE172864A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE848932A publication Critical patent/BE848932A/fr

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433Serine endopeptidases (3.4.21)
    • G01N2333/96441Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444Factor X (3.4.21.6)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BE172864A 1975-12-01 1976-11-30 Procede pour determiner in vitro dans le sang l'inhibiteur du facteur x active, BE848932A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7513495A SE419871B (sv) 1975-12-01 1975-12-01 Sett att bestemma aktiviteten hos faktor xa-inhibitor i blod

Publications (1)

Publication Number Publication Date
BE848932A true BE848932A (fr) 1977-05-31

Family

ID=20326201

Family Applications (1)

Application Number Title Priority Date Filing Date
BE172864A BE848932A (fr) 1975-12-01 1976-11-30 Procede pour determiner in vitro dans le sang l'inhibiteur du facteur x active,

Country Status (15)

Country Link
US (1) US4139415A (fr)
JP (1) JPS5915640B2 (fr)
AT (1) AT348687B (fr)
AU (1) AU508343B2 (fr)
BE (1) BE848932A (fr)
CA (1) CA1060324A (fr)
CH (1) CH625052A5 (fr)
DE (1) DE2654189C3 (fr)
DK (1) DK537676A (fr)
FI (1) FI63494C (fr)
FR (1) FR2334109A1 (fr)
GB (1) GB1562808A (fr)
NL (1) NL7613376A (fr)
NO (1) NO148960C (fr)
SE (1) SE419871B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2757992A1 (de) 1977-12-24 1979-06-28 Boehringer Mannheim Gmbh Verfahren zur prothrombin-bestimmung
US4302538A (en) * 1978-03-27 1981-11-24 Ortho Diagnostics Inc. Buffer system in an anti-thrombin III test
SE422081B (sv) * 1979-08-22 1982-02-15 Ird Biomaterial Ab Sett att pavisa proteolytiska enzymer
CA1161432A (fr) * 1980-02-12 1984-01-31 Lars G. Svendsen Derives de tripeptides et application pour le dosage des enzymes
WO1982001377A1 (fr) * 1980-10-09 1982-04-29 Lill Helmut Procede de determination d'une bm ('binding moderately') antithrombine
US4753875A (en) * 1981-11-02 1988-06-28 Ryan James W Method for assaying proteases with tagged proteinaceous inhibitors
US5221614A (en) * 1988-03-03 1993-06-22 Nippon Shoji Kabushiki Kaisha Method and reagent for determining the biological activity of antithrombin III by measuring coagulation time
GB9602166D0 (en) * 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
DE19634312A1 (de) * 1996-08-24 1998-02-26 Behringwerke Ag Verfahren zur Herstellung von Faktor V-Mangelplasma und ein so erhaltenes Mangelplasma
US6432658B1 (en) 2000-09-13 2002-08-13 Affinity Biologicals, Inc. Method for measuring antithrombin activity
EP2818871A1 (fr) * 2013-06-28 2014-12-31 Roche Diagniostics GmbH Moyens et procédés pour étalonnage universel de tests anti-facteur Xa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE380257B (sv) * 1972-05-02 1975-11-03 Bofors Ab Nya diagnostiskt verksamma substrat med hog specificitet till trombin och andra proteolytiska enzymer av typen peptidyl-peptid-hydrolaser
US3985618A (en) * 1975-05-02 1976-10-12 Irving Innerfield Method for detection of thrombosis and prethrombosis

Also Published As

Publication number Publication date
FI763446A (fr) 1977-06-02
SE419871B (sv) 1981-08-31
CH625052A5 (fr) 1981-08-31
SE7513495L (sv) 1977-06-02
FI63494C (fi) 1983-06-10
AT348687B (de) 1979-02-26
NL7613376A (nl) 1977-06-03
AU2006176A (en) 1978-06-08
NO148960C (no) 1984-01-18
JPS5297792A (en) 1977-08-16
DE2654189A1 (de) 1977-06-08
GB1562808A (en) 1980-03-19
DK537676A (da) 1977-06-02
NO148960B (no) 1983-10-10
ATA891076A (de) 1978-07-15
FI63494B (fi) 1983-02-28
DE2654189C3 (de) 1985-10-03
CA1060324A (fr) 1979-08-14
JPS5915640B2 (ja) 1984-04-10
FR2334109B1 (fr) 1982-03-12
US4139415A (en) 1979-02-13
NO764081L (fr) 1977-06-02
FR2334109A1 (fr) 1977-07-01
DE2654189B2 (de) 1979-03-08
AU508343B2 (en) 1980-03-20

Similar Documents

Publication Publication Date Title
BE857722A (fr) Procede pour la preparation d'ethylene-glycol
BE809088A (fr) Procede pour le fractionnement du sang
RO69285A (fr) Procede pour la preparation du diacetate d'ethyldiene
FR2342072A1 (fr) Composition enzymatique pour le traitement de la cataracte
BE860377A (fr) Procede pour fractionner les elements figures du sang
BE848932A (fr) Procede pour determiner in vitro dans le sang l'inhibiteur du facteur x active,
RO70854A (fr) Procede pour la preparation des metha-aryloxybenzaldehydes
RO72547A (fr) Procede pour la preparation des esters 2',3,6'-trichlore-4-cyan-4'-benzoylureidodiphenyliques
BE818211A (fr) Procede pour la determination de la teneur du sang en plasminogene
RO70462A (fr) Procede pour la preparation des 3-halomethylcephem
RO72910A (fr) Procede pour la preparation continue d'acide perpropionique en solution benzenique
RO71572A (fr) Procede pour la preparation des oxycarbamates n-sulphenyles
RO71066A (fr) Procede pour la preparation des 2-chlorsulfinylazetidin-4-ones
FR2313380A1 (fr) Procede pour la preparation de methacrylate de glycidyle
BE856740A (fr) Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
RO77935A (fr) Procede pour la preparation des cis-4a-arylo tahydro-1h-2-pyrinidine s
RO72831A (fr) Procede pour la preparation des fenilpyperazines
RO79428A2 (fr) Composition medicamenteuse pour le traitement des dermatoses
PT64691B (fr) Procede pour la preparation d'acides 6,11-di-hydro-11-oxo-dibenz /b,e/ oxepin-alcanoiques
PT66201A (fr) Procede et composition pour la therapeutique des maladies circulatoires cerebrales
RO76126A2 (fr) PROCEDE POUR LA PREPARATION DES ACIDES ANTHRAQUINONE-2,6 ET 2,7-œISULFONIQUES
PT66890B (fr) Procede pour la preparation des aryloxy-1 amino-3 propanol-2
BE864577A (fr) Composition et procede pour determiner l'activite transferasique et proteasique
RO70052A (fr) Procede pour la preparation des 7-alcoxy-3-chloremethylecephemes
RO83713A (fr) Procede pour la preparation des haloacylamides

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: PHARMACIA A.B.

Effective date: 19841130